Public-private partnerships and supportive state legislative measures aimed at growing biomanufacturing capacity in the United States are providing significant economic on-shoring value, and are essential for producing life-saving medications, vaccines, and therapies that benefit patients worldwide. Learn about some of the dynamic state and regional strategic partnerships and incentives that are accelerating domestic biomanufacturing, creating jobs, and expanding market reach during this important public policy discussion. Representatives from state government and industry will share how they are driving new levels of cooperation and investment in the growing biomanufacturing field.